01—Abstract
Summary
Summary of the 8-K filed July 27, 2026. Cited figures are marked; the original filing is the authoritative source.
Welltower reported second-quarter 2026 results that beat the prior-year period on operating metrics, with normalized FFO per diluted share of $1.60a, up 25.0% year over year, and total portfolio same store NOI growth of 15.5%, led by a 20.5% increase in the Seniors Housing Operating (SHO) portfolio.
SHO organic same store revenue rose 9.2%, driven by 330 bps of occupancy gain and 5.2% RevPOR growth. GAAP net income attributable to common stockholders was $0.61b per diluted share, up from $0.45, though the filing also shows large gains on dispositions in the period. Investment activity was heavy: $9.4 billion of pro rata gross investments closed in the first half, plus $6.1 billion closed or under contract after quarter end, with the Amica Canadian acquisition the largest single item.
Dispositions and loan repayments totaled $3.6 billionc year to date, including $1.9 billion of Outpatient Medical sales. The balance sheet is described as strong, with Net Debt to Adjusted EBITDA of 2.99x, about $9.5 billion of available liquidity, and net debt to consolidated enterprise value of 8.9%, down from 10.1%. The company issued C$1.15 billion of senior unsecured notes in July at a weighted-average coupon of 3.95%.
The board raised the quarterly dividend 15% to $0.85d. Management raised its 2026 normalized FFO guidance to $6.36-$6.44 per diluted share from $6.21-$6.35, but lowered its net income guidance to $3.11-$3.19 from $3.24-$3.38. The company attributes the strong quarter to acquisitions and operating momentum, but investors should note that the lower GAAP net income outlook and the reliance on continued acquisitions and dispositions are important considerations.
The quarter was not solely organic. Dispositions were significant, and the company has a remaining pipeline of eight OM properties to sell by year end. Forward-looking statements and risk factors cover macroeconomic conditions, reimbursement policy, operator health, and capital market access, which investors should weigh against the reported growth figures.
02—Key points
Key Highlights
- Normalized FFO of $1.60 per diluted share, up 25.0% year over year; full-year 2026 normalized FFO guidance raised to $6.36-$6.44 from $6.21-$6.35.
- Total portfolio same store NOI grew 15.5%, with SHO SSNOI up 20.5% and SHO organic same store revenue up 9.2% on 330 bps of occupancy gain and 5.2% RevPOR growth.
- GAAP net income attributable to common stockholders of $0.61 per diluted share, versus $0.45 a year earlier; full-year net income guidance lowered to $3.11-$3.19 from $3.24-$3.38.
- Gross investment activity of $9.4 billion in the first half of 2026 plus $6.1 billion closed or under contract after quarter end, led by the Amica Canadian portfolio acquisition (C$4.1 billion pro rata).
- Dispositions and loan repayments of $3.6 billion year to date, including $1.9 billion of Outpatient Medical sales, with eight OM properties still expected to close before year end 2026.
- Balance sheet metrics: Net Debt to Adjusted EBITDA of 2.99x, approximately $9.5 billion of available liquidity, and net debt to consolidated enterprise value of 8.9% versus 10.1% a year earlier.
- Quarterly dividend raised 15% to $0.85 per share, payable August 20, 2026, the company's 221st consecutive quarterly cash dividend.
03—Questions
Frequently Asked Questions
Why did normalized FFO guidance rise while net income guidance fell?
The filing's Exhibit 3 shows that the guidance change is driven mainly by accounting items rather than operations. Net income guidance dropped because of lower expected gains on real estate dispositions, which fell from $576 million to $545 million, and because depreciation and amortization rose from $2.67 billion to $2.85 billion. Normalized FFO excludes those items, and its guidance increased to reflect stronger same store NOI growth, now expected at 13.75%-16.00% on a blended basis.
How much of the growth is from acquisitions versus organic operations?
Both contributed. Same store NOI growth of 15.5% reflects organic performance in the same store pool, which excludes recent acquisitions for five quarters. Total gross investments of $9.6 billion year to date, including the Amica acquisition that closed April 1, 2026, add to reported results but are not captured in same store figures. The company's guidance includes only acquisitions announced or closed to date, so further investment would be upside to the outlook.
Is the dividend increase sustainable given the payout ratio?
The normalized FFO payout ratio for the quarter was 46%, down from 52% a year earlier, and the $0.85 quarterly dividend is about 53% of the midpoint of full-year normalized FFO guidance ($6.40). Management cites durable cash flow growth and balance sheet strength as support. Future dividends remain subject to board approval.
What are the main risks highlighted in the filing?
The forward-looking statements cite macroeconomic conditions, interest rates, capital market access, and government reimbursement policy for Medicare and Medicaid. They also flag operator and tenant financial health, the ability to re-lease vacancies and reinvest disposition proceeds at similar yields, and currency movements, since a significant portion of NOI is in the UK and Canada. Dispositions yield 6.8% on expected proceeds, and sales of OM properties are a meaningful part of the plan.
04—Continue